COV-19 IDX Trademark

Trademark Overview


On Friday, September 11, 2020, a trademark application was filed for COV-19 IDX with the United States Patent and Trademark Office. The USPTO has given the COV-19 IDX trademark a serial number of 90173914. The federal status of this trademark filing is REGISTERED as of Tuesday, September 28, 2021. This trademark is owned by Ipsum Diagnostics LLC. The COV-19 IDX trademark is filed in the Pharmaceutical Products and Medical & Beauty Services & Agricultural Services categories with the following description:

Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, SARS-CoV-2 (COVID-19); Diagnostic preparations for medical purposes; all the foregoing related to the diagnosis of COVID-19

Medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Medical diagnostic testing, monitoring and reporting services; Medical testing for diagnostic or treatment purposes in the field of SARS-CoV-2 (COVID-19); all the foregoing related to the treatment or diagnosis of COVID-19
cov-19 idx

General Information


Serial Number90173914
Word MarkCOV-19 IDX
Filing DateFriday, September 11, 2020
Status700 - REGISTERED
Status DateTuesday, September 28, 2021
Registration Number6497097
Registration DateTuesday, September 28, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 13, 2021

Trademark Statements


Disclaimer with Predetermined Text"COV-19"
Goods and ServicesDiagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, SARS-CoV-2 (COVID-19); Diagnostic preparations for medical purposes; all the foregoing related to the diagnosis of COVID-19
Goods and ServicesMedical analysis services for diagnostic and treatment purposes provided by medical laboratories; Medical diagnostic testing, monitoring and reporting services; Medical testing for diagnostic or treatment purposes in the field of SARS-CoV-2 (COVID-19); all the foregoing related to the treatment or diagnosis of COVID-19
Pseudo MarkCOV-NINETEEN IDX; COV-ONE NINE IDX

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, October 19, 2020
Primary Code005
First Use Anywhere DateSunday, March 15, 2020
First Use In Commerce DateSunday, March 15, 2020

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, October 19, 2020
Primary Code044
First Use Anywhere DateSunday, March 15, 2020
First Use In Commerce DateSunday, March 15, 2020

Trademark Owner History


Party NameIpsum Diagnostics LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressAtlanta, GA 30350

Party NameIpsum Diagnostics LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressAtlanta, GA 30350

Party NameIpsum Diagnostics LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressAtlanta, GA 30350

Trademark Events


Event DateEvent Description
Tuesday, September 28, 2021REGISTERED-PRINCIPAL REGISTER
Tuesday, July 13, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 13, 2021PUBLISHED FOR OPPOSITION
Wednesday, June 23, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, June 5, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, June 1, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, June 1, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, June 1, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, March 14, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sunday, March 14, 2021NON-FINAL ACTION E-MAILED
Sunday, March 14, 2021NON-FINAL ACTION WRITTEN
Friday, February 26, 2021ASSIGNED TO EXAMINER
Monday, October 19, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, September 15, 2020NEW APPLICATION ENTERED IN TRAM